Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine targeting serogroups A, C, W, Y, and X when co-administered with routine childhood vaccines at ages 9 months and 15 months in Mali: a single-centre, double-blind, randomised, controlled, phase 3, non-inferiority trial
在马里，一项单中心、双盲、随机、对照、3期非劣效性试验评估了在9月龄和15月龄儿童中，与常规儿童疫苗联合接种针对A、C、W、Y和X血清群的五价脑膜炎球菌结合疫苗的安全性和免疫原性。
期刊:Lancet
影响因子:88.5
doi:10.1016/S0140-6736(25)00046-7
Diallo, Fatoumata; Haidara, Fadima C; Tapia, Milagritos D; Dominguez Islas, Clara P; Alderson, Mark R; Hausdorff, William P; Martellet, Lionel; Hosken, Nancy; Kapse, Dhananjay; Kulkarni, Prasad S; Townsend-Payne, Kelly; Vanni, Francesca; Posavad, Christine M; Sow, Samba O; Kotloff, Karen L; Chen, Wilbur H
